Dariusz Belowski

Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner

Łukasz Bułdak, Grzegorz Machnik, Rafał Jakub Bułdak et al. · Pharmacological Reports · 2015 · 67 citations

Inflammation, Cytokine, Protein Kinase A +12

The effect of statins and fibrates on interferon-γ and interleukin-2 release in patients with primary type II dyslipidemia

Bogusław Okopień, Robert Krysiak, Jan Kowalski et al. · Atherosclerosis · 2004 · 58 citations

Inflammation, Immunology, Chronic Inflammation +4

Monocyte Release of Tumor Necrosis Factor-α and Interleukin-1β in Primary Type IIa and IIb Dyslipidemic Patients Treated With Statins or Fibrates

Bogusław Okopień, Robert Krysiak, Jan Kowalski et al. · Journal of Cardiovascular Pharmacology · 2005 · 57 citations

Immunology, Pathology, Primary Type Iia +21

Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome

J Wysocki, Dariusz Belowski, Maria Kalina et al. · International Journal of Clinical Pharmacology and Therapeutics · 2004 · 52 citations

Superoxide dismutase 1 and glutathione peroxidase 1 are involved in the protective effect of sulodexide on vascular endothelial cells exposed to oxygen–glucose deprivation

Bożena Gabryel, Karolina Jarząbek, Grzegorz Machnik et al. · Microvascular Research · 2015 · 34 citations

Redox Signaling, Biochemistry, Medicine +10